Form 4: Amneal Pharmaceuticals Director Sells Shares

Amneal Pharmaceuticals Director Deborah M. Autor reported a sale of 34,819 shares of Class A Common Stock on May 11, 2026, for a weighted average price of $12.94 per share.

Summary

• Deborah M. Autor, a Director at Amneal Pharmaceuticals, Inc., sold 34,819 shares of Class A Common Stock on May 11, 2026.
• The sale was executed at a weighted average price of $12.94 per share, with individual transactions ranging from $12.75 to $13.27.
• Following the transaction, Ms. Autor beneficially owns 93,660 shares of Class A Common Stock directly.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative sentiment due to a director selling a notable number of shares, which could be perceived as a bearish signal by investors.

Negatives

• Director Deborah M. Autor sold a significant number of shares (34,819) of Class A Common Stock.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that insider selling, particularly by directors, can sometimes be interpreted by the market as a signal of reduced confidence or a belief that the stock may be fully valued, though it can also be for personal financial planning reasons.

Stakeholder Impact

• Shareholders may view this sale negatively, potentially leading to short-term downward pressure on the stock price.

Key Dates

Recommendation

While insider selling can be a concern, the sale by Director Autor is a single transaction and does not provide enough information on its own to warrant a strong sell. It is prudent to hold and monitor further developments and company performance.

Keywords

Amneal Pharmaceuticals, AMRX, Form 4, Insider Trading, Stock Sale, Director Transaction, Class A Common Stock